Evidence-Based Medicine Guidelines
Hydroxyurea for psoriasis
Hydroxyurea for psoriasis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Hydroxyurea for Psoriasis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453223/all/Hydroxyurea_for_psoriasis.
Hydroxyurea for psoriasis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453223/all/Hydroxyurea_for_psoriasis. Accessed May 24, 2022.
Hydroxyurea for psoriasis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453223/all/Hydroxyurea_for_psoriasis
Hydroxyurea for Psoriasis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 May 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453223/all/Hydroxyurea_for_psoriasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea for psoriasis
ID - 453223
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453223/all/Hydroxyurea_for_psoriasis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
